Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tamas Czompoly"'
Autor:
Francisc Boda, Krisztina Banfai, Kitti Garai, Bela Kovacs, Attila Almasi, Dalma Scheffer, Reka Lambertne Sinkler, Robert Csonka, Tamas Czompoly, Krisztian Kvell
Publikováno v:
Journal of Venomous Animals and Toxins including Tropical Diseases, Vol 26 (2020)
Abstract Background: Certain environmental toxins permanently damage the thymic epithelium, accelerate immune senescence and trigger secondary immune pathologies. However, the exact underlying cellular mechanisms and pathways of permanent immune into
Externí odkaz:
https://doaj.org/article/463e0e8db97843f39b7b38563b75e673
Autor:
Francisc, Boda, Krisztina, Banfai, Kitti, Garai, Bela, Kovacs, Attila, Almasi, Dalma, Scheffer, Reka Lambertne, Sinkler, Robert, Csonka, Tamas, Czompoly, Krisztian, Kvell
Publikováno v:
The Journal of Venomous Animals and Toxins Including Tropical Diseases
Background: Certain environmental toxins permanently damage the thymic epithelium, accelerate immune senescence and trigger secondary immune pathologies. However, the exact underlying cellular mechanisms and pathways of permanent immune intoxication
Autor:
György Nagyéri, Tamas Czompoly, Magnus Maloy, Gyula Kulcsár, Zoltan Rekasi, Dalma Scheffer, Marianna Kiss-Merki
Publikováno v:
Cellular Signalling. 65:109426
Genetic and epigenetic regulation as well as immune surveillance are known defense mechanisms to protect organisms from developing cancer. Based on experimental evidence, we proposed that small metabolically active molecules accumulating in cancer ce
Autor:
Jozsef L. Varga, Tamas Czompoly, Gabor Halmos, Artur Plonowski, Zoltan Rekasi, Andrew V. Schally
Publikováno v:
Scopus-Elsevier
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the proliferation of various human cancers in vitro and in vivo by mechanisms that include apparent direct effects through specific binding sites expressed on tumors and that differ from
Autor:
Andrew V. Schally, Kate Groot, Gabor Halmos, Jozsef L. Varga, Patricia Armatis, Tamas Czompoly, Zoltan Rekasi
Publikováno v:
Endocrinology. 141:2120-2128
Antagonists of GH-releasing hormone (GHRH) and vasoactive intestinal peptide (VIP) inhibit the proliferation of various tumors in vitro and in vivo, but a comparison of their antitumor effects and mechanisms of action has not been reported to date. W
Autor:
Miklós Poór, Beáta Lemli, Péter Vilmányi, Ágnes Dombi, Zoltán Nagymihály, Eszter Borbála Both, Nándor Lambert, Tamás Czömpöly, Lajos Szente
Publikováno v:
Metabolites, Vol 13, Iss 3, p 446 (2023)
Mycotoxins are toxic metabolites of molds. Chronic exposure to alternariol, zearalenone, and their metabolites may cause the development of endocrine-disrupting and carcinogenic effects. Alternariol-3-glucoside (AG) and alternariol-9-monomethylether-
Externí odkaz:
https://doaj.org/article/26895f758bec40a39f6a685dc047f55b
Autor:
Jozsef L. Varga, Gabor Halmos, Tamas Czompoly, Magdalena Krupa, Zoltan Rekasi, Andrew V. Schally
Antagonists of GHRH inhibit the growth of various human tumors, including prostate cancer, but the tumoral receptors mediating the antiproliferative effect of GHRH antagonists have not been clearly identified. Recently, we demonstrated that human can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199531c35e3d41795b70ba9d8da28d58
Autor:
Balazs Csernus, Jozsef L. Varga, Tamas Czompoly, Andrew V. Schally, Artur Plonowski, Zoltan Rekasi
Publikováno v:
The Prostate. 48(3)
Background Prostate-specific antigen (PSA) is the best tumor marker for diagnosis and prognosis of prostatic carcinoma. The secretion of PSA from LNCaP human prostate cancer cells is influenced by acute stimuli such as vasoactive intestinal peptide (
Peptide analogs of growth hormone-releasing hormone (GHRH) can potentially interact with vasoactive intestinal peptide (VIP) receptors (VPAC 1 -R and VPAC 2 -R) because of the structural similarities of these two hormones and their receptors. We synt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f227328699f4f8e2daa974c5da5c71
https://europepmc.org/articles/PMC15574/
https://europepmc.org/articles/PMC15574/
Publikováno v:
Scopus-Elsevier
The proliferation of various tumors is inhibited by the antagonists of growth hormone-releasing hormone (GHRH) in vitro and in vivo , but the receptors mediating the effects of GHRH antagonists have not been identified so far. Using an approach based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e7108406ff1e3d27be44a214632e476